4//SEC Filing
Martinez Maria E 4
Accession 0001214659-21-001095
CIK 0001576263other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:47 PM ET
Size
26.5 KB
Accession
0001214659-21-001095
Insider Transaction Report
Form 4
Martinez Maria E
Director
Transactions
- Sale
Common Stock
2021-01-29$201.99/sh−960$193,911→ 8,534 total - Sale
Common Stock
2021-01-29$197.14/sh−50$9,857→ 10,925 total - Sale
Common Stock
2021-01-29$198.48/sh−250$49,621→ 10,675 total - Sale
Common Stock
2021-01-29$205.26/sh−975$200,125→ 4,775 total - Sale
Common Stock
2021-01-29$206.63/sh−1,100$227,297→ 3,675 total - Sale
Common Stock
2021-01-29$200.05/sh−719$143,839→ 9,956 total - Sale
Common Stock
2021-01-29$207.82/sh−200$41,565→ 3,475 total - Sale
Common Stock
2021-01-29$200.90/sh−462$92,818→ 9,494 total - Sale
Common Stock
2021-01-29$203.43/sh−1,579$321,219→ 6,955 total - Exercise/Conversion
Common Stock
2021-01-29$39.76/sh+7,500$298,200→ 10,975 total - Sale
Common Stock
2021-01-29$204.43/sh−1,205$246,333→ 5,750 total - Exercise/Conversion
Non Qualified Stock Option (right to buy)
2021-01-29−7,500→ 17,500 totalExercise: $39.76Exp: 2028-12-05→ CommonStock (7,500 underlying)
Footnotes (11)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2020.
- [F10]This transaction was executed in multiple trades at prices ranging from $207.74 to $207.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F11]The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.
- [F2]This transaction was executed in multiple trades at prices ranging from $198.23 to $199.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $199.51 to $200.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $200.55 to $201.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $201.63 to $202.545. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $202.97 to $203.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $204.00 to $204.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]This transaction was executed in multiple trades at prices ranging from $205.00 to $205.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F9]This transaction was executed in multiple trades at prices ranging from $206.215 to $206.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001761768
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:47 PM ET
- Size
- 26.5 KB